To predict testicular involvement in patients diagnosed with Fournier’s gangrene (FG) using the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score and the site other than lower limb (SIARI) score. The medical records of 51 patients operated for FG in our clinic between December 2012 and April 2022 were evaluated retrospectively in this study. Patients’ demographics, and laboratory test results were compared with the testisticular involvement status. Patients with testisticular involvement (n = 10) were compared with patients without testicular involvement (n = 41). The SIARI score at initial admission was analysed using logistic regression analyses for its performance in predicting testicular involvement with FG. Receiver operating characteristics (ROC) curves and the area under the receiver operating characteristic curve (AUROC) were used to evaluate its discriminating ability. The SIARI score had modest performance for diagnosing testicular involvement in FG patients, with ROC analysis showing an AUROC value of 0.83 (p < 0.001). With a SIARI cut-off score of ≥ 3, the sensitivity was 90% and the specificity was 68%. For a SIARI cut-off score of ≥ 5, the sensitivity was 40% and the specificity was 97%. The ability of the SIARI score to discriminate FG with testicular involvement is modest. The SIARI score should be employed cautiously as a routine diagnostic tool for the prediction of testicular involvement in FG at the initial admission. More research is needed to develop a better understanding of the relationship between the SIARI score and testicular involvement in FG.
This study aimed to observe the effect of the location and severity of partial ureteral obstruction, based on ureteropelvic and ureterovesical junction strictures, on stone formation. Forty 8-week-old male rats were divided into five groups: control and mild/severe proximal or distal ureteral obstruction groups. A partial ureteral obstruction was created according to the type of obstruction by a surgical procedure. After 5 days of intraperitoneal glyoxylate injection, the urine, blood samples, and kidney tissues of the rats were examined. There were significant differences in urine citrate concentrations, pH values, and oxalate/creatinine, citrate/creatinine, and calcium/creatinine ratios between the groups (all p < 0.05). The mean citrate/creatinine ratio was 21.13 ± 0.44 in the control group, 17.31 ± 3.82 in the distal obstruction group, and 15.48 ± 1.87 in the proximal obstruction group. Regarding the degree of obstruction, urine citrate concentrations, pH values, and citrate/creatinine were lower, and the oxalate/creatinine ratio was higher in severe obstruction than in mild obstruction (p < 0.05). This study represents an initial attempt to evaluate a model of partial ureteral obstruction and urolithiasis. The findings indicate that obstruction alters urinary parameters, such as citrate and pH, indirectly increasing the risk of stone formation. Furthermore, stone formation in an obstructed urinary system appears to be a complex process. However, metabolic evaluation and treatment may help prevent stone formation in patients with ureteral obstruction.
Objective: Sarcopenia is increasingly recognized as a marker of frailty and a predictor of adverse outcomes in surgical oncology. However, its role in patients undergoing radical prostatectomy (RP) for localized prostate cancer (PCa) remains unclear.Methods: We retrospectively analyzed 165 men who underwent RP between 2015 and 2025 at a single institution. Sarcopenia was assessed using preoperative CT-derived skeletal muscle index (SMI). Perioperative complications, pathological outcomes, urinary continence, erectile function, biochemical recurrence (BCR), and all-cause mortality (ACM) were com-pared between sarcopenic and non-sarcopenic patients. Statistical analyses included the Mann–Whitney U test, chi-square test, Kaplan–Meier analysis with the log-rank test, and Cox proportional hazards regression.Results: Of the cohort, 75 patients (45.5%) were sarcopenic. These patients were older (median age 69 vs. 66 years, p=0.005) and had higher comorbidity scores (CCI ≥5: 56.0% vs. 32.2%, p=0.002). Major complications (Clavien-Dindo ≥3) occurred more frequently in the sarcopenic group (10.7% vs. 1.1%, p=0.007), although no perioperative mortality was observed. Continence status at 12 months was comparable between the groups (p=0.373). IIEF-5 scores were lower in sarcopenic patients at 12 months (median, 10 vs. 12; p=0.021); however, baseline IIEF-5 scores also differed significantly between the groups. During a median follow-up of 37 months, 65 patients developed BCR and 11 died (7 sarcopenic). Cumulative incidence of biochemical recurrence was 44% at the median follow-up. Although sarcopenic patients showed a higher recurrence trend (≈65% vs. 37%), no statistically significant difference was observed (p=0.267). In Cox Regression analysis, sarcopenia did not appear to significantly predict BCR (HR 0.75, 95% CI 0.45–1.24, p=0.272).Conclusions: Preoperative sarcopenia may be associated with increased major perioperative complications and impaired erectile function following RP. However, it was not significantly associated with BCR in this cohort. Sarcopenia may primarily serve as an indicator of surgical vulnerability rather than oncological prognosis.